Journal profile · Chemical Engineering-Bioengineering
Frontiers in Bioengineering and Biotechnology
ISSN 2296-4185 · Frontiers Media S.A. · Switzerland
Frontiers in Bioengineering and Biotechnology: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 5.72; fully open access; APC charged, amount not published; median 59 days to acceptance (174 articles, last 24 months); 1,221 articles in 2025; indexed in SCIE and Scopus; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: The journal no longer accepts papers concerning simple bibliometric studies. Authors are still welcome to submit Systematic Reviews using publicly available data, but these must adhere to the PRISMA guidelines and have a conclusion related to bioengineering and biotechnology research. Studies without this primary focus will be transferred to a more applicable journal. Source ↗Publisher website ·
Scope
Aims, scope and focus
Frontiers in Bioengineering and Biotechnology is published by Frontiers Media S.A. and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bone Tissue Engineering Materials, 3D Printing in Biomedical Research and Electrospun Nanofibers in Biomedical Applications, together about 28.3% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Bioengineering and Biotechnology is a multidisciplinary journal that accelerates the development of biological diagnostics, therapies, devices, and technologies. Indexed in PubMed Central, Scopus, DOAJ, and Web of Science (SCIE), among others. The journal is led by Field Chief Editor Ranieri Cancedda (Professor Emeritus, Genova University, Italy) and welcomes submissions relating to the development and applications of new biological diagnostics, therapies, processes or innovative devices involving the use of cells, bioactive molecules and biomaterials alone or in combination. The journal aims to enable the breakthroughs of the future in the field and bridge the gap between discoveries in the basic sciences and their application to improve our lives. Topics include, but are not limited to: biofabrication biomaterials biomechanics bioprocess engineering biosafety and biosecurity biosensors and biomolecular electronics industrial biotechnology nanobiotechnology organoids and organ-on-a-chip preclinical cell and gene therapy synthetic biology tissue engineering and regenerative medicine. In particular, the journal welcomes submissions which support and advance the UN’s Sustainable Development Goals (SDGs), notably SDG 3: ensure healthy lives and promote well-being for all at all ages. Manuscripts that focus solely on the development or application of statistical, computational, and machine learning methods without relevance to biological or biomedical phenomena are not suitable for publication in this journal. Similarly, studies that are clinical or purely epidemiological, including those that identify risk factors or develop predictive models for human diseases, are not within the scope of this journal. Clinical Trials are not accepted in this journal, under any article type that Frontiers in Biotechnology and Bioengineering offers. The journal no longer accepts papers concerning simple bibliometric studies. Authors are still welcome to submit Systematic Reviews using publicly available data, but these must adhere to the PRISMA guidelines and have a conclusion related to bioengineering and biotechnology research. Studies without this primary focus will be transferred to a more applicable journal. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not ad
From the journal's Aims & Scope
Research area (LetPub): Chemical Engineering-Bioengineering
Editorial board by country: none in mainland China; most named United States 4, Italy 3, Spain 2, Switzerland 2, Mexico 2 (17 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bone Tissue Engineering MaterialsEngineering10.5%
- 3D Printing in Biomedical ResearchEngineering8.9%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science8.9%
- Tissue Engineering and Regenerative MedicineMedicine6.9%
- Microbial Metabolic Engineering and BioproductionBiochemistry, Genetics and Molecular Biology4.9%
- Orthopaedic implants and arthroplastyMedicine4.3%
- Nanoplatforms for cancer theranosticsEngineering4.2%
- Biofuel production and bioconversionEngineering3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
| Minor | Engineering, Biomedical | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Engineering Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Engineering | Zone 3 |
| Minor | Multidisciplinary Sciences | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EI CompendexWeb of SciencePMCINSPECPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.72LetPub ·
- Impact factor (publisher)
- 5.8Publisher website ·
- CiteScore 2026-06
- 10.6LetPub ·
- CiteScore (publisher)
- 10.6Publisher website ·
- SJR 2026-06
- 1.02LetPub ·
- SNIP 2026-06
- 1.21LetPub ·
- h-index
- 176OpenAlex ·
- i10-index
- 6,667OpenAlex ·
- 2-year mean citedness
- 6.19OpenAlex ·
- Self-citation rate
- 3.4%LetPub ·
- Share of gold OA articles
- 99.97%LetPub ·
Volume
- Articles per year
- 1,120LetPub ·
Articles by year OpenAlex count · 15,008 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,088 | 1,088 | 644 |
| 2025 | 1,221 | 1,221 | 6,179 |
| 2024 | 1,247 | 1,247 | 15,198 |
| 2023 | 1,759 | 1,759 | 29,594 |
| 2022 | 2,566 | 2,566 | 56,102 |
| 2021 | 1,470 | 1,470 | 49,409 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
59 daysMedian, submission to acceptance · P25–P75 38 days – 90 days
- Acceptance to online
- median 27 days (174 articles)
- Submission to online
- median 87 days
- Sample
- 174 articles with submission and acceptance dates (2,435 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 3,150 | Yes | CC BY | |
| OpenAlex | CHF 3,150 | — | — | |
| LetPub | USD 3,295 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Keywords
- 5–8
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Frontiers participates in CrossMark to maintain published content and alert readers to changes. Model summary
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures, tables, and images are published under a Creative Commons CC-BY license; permission must be obtained for copyrighted material from other sources. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Articles are published open access under CC-BY v4.0; authors retain copyright. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2296-4185
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Bioengineering and Biotechnology
What CAS zone is Frontiers in Bioengineering and Biotechnology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Frontiers in Bioengineering and Biotechnology is in Zone 3 of Biology, and in Zone 3 of the minor category Biotechnology & Applied Microbiology / Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Bioengineering and Biotechnology?
The latest impact factor listed by LetPub is 5.72; CiteScore 10.6, h-index 176.
How long does peer review take at Frontiers in Bioengineering and Biotechnology?
Based on the dates recorded on 174 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 59 days (interquartile range 38–90 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Frontiers in Bioengineering and Biotechnology based?
Of the 17 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (4), Italy (3) and Spain (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Bioengineering and Biotechnology?
According to LetPub and DOAJ records, Frontiers in Bioengineering and Biotechnology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists EI Compendex, Web of Science, PMC and INSPEC; that list has not been checked against each database.
Is Frontiers in Bioengineering and Biotechnology open access, and what is the APC?
Frontiers in Bioengineering and Biotechnology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .